Drug | DrugBank ID | Correlation Score | Affected Pathways (%) | Description |
---|---|---|---|---|
Crizotinib | DB08865 | −0.64 | 74.07 | Used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC). |
Olmesartan | DB00275 | −0.85 | 55.56 | Used for the treatment of hypertension. |
Sepantronium | – | −0.21 | 74.07 | Clinical trials in advanced non-small-cell lung cancer. |
Bortezomib | DB00188 | −0.52 | 62.96 | Used for the treatment of multiple myeloma. |
Fluspirilene | DB04842 | −0.5 | 55.56 | Used for the treatment of schizophrenia. |
Vistusertib | DB11925 | −0.44 | 66.67 | Under investigation for the treatment of Advanced Gastric Adenocarcinoma. |
Olaparib | DB09074 | −0.44 | 66.67 | A poly (ADP-ribose) polymerase (PARP) inhibitor indicated for the treatment of Ovarian and Breast Cancer. |
Tivozanib | DB11800 | −0.44 | 66.67 | Used in trials for the treatment of solid tumors, Ovarian Cancer, Glioblastoma, Prostate Cancer among others. |
Belinostat | DB05015 | −0.43 | 55.56 | Used for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). |